Illustrative image – not actual.Lupin, a Mumbai-based pharma company, is all set to expand its bulk drug manufacturing site at Dabhasa near Vadodara, Gujarat.
The company will invest Rs 270 crore in the expansion. As per its expansion plan, Lupin intends to make around eighty different varieties of bulk drugs at the Dabhasa plant. The additional capacity will be to the tune of 1,480 tonne per annum. However, the company has not yet procured any additional land for the expansion.
The company plans to expand the unit to add more bulk drugs belonging to the categories of anti-cholesterol, cardiac, neuropathic, respiratory, and anti-infectives among others.
